Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Abdominal Radiology
Published in: Abdominal Radiology 1/2012

01-02-2012

Contrast-enhanced ultrasound in abdominal imaging

Authors: Carlos Nicolau, Tomás Ripollés

Published in: Abdominal Radiology | Issue 1/2012

Login to get access

Abstract

The administration of a contrast agent is considered an essential tool to evaluate abdominal diseases using Ultrasound. The most targeted organ is the liver, especially to characterize focal liver lesions and to assess the response to percutaneous treatment. However, the expanding abdominal indications of contrast-enhanced ultrasound make this technique an important tool in the assessment of organ perfusion including the evaluation of ischemic, traumatic, and inflammatory diseases.
Literature
1.
Wilson SR, Burns PN (2010) Microbubble-enhanced US in body imaging: what role? Radiology 257(1):24–39PubMedCrossRef
2.
Claudon M, Cosgrove D, Albrecht T, et al. (2008) Guidelines and good clinical practice recommendations for contrast-enhanced ultrasound (CEUS) update 2008. Ultraschall Med 29:28–44PubMedCrossRef
3.
Wilson SR, Greenbaum LD, Goldberg BB (2009) Contrast-enhanced ultrasound: what is the evidence and what are the obstacles? AJR Am J Roentgenol 193(1):55–60PubMedCrossRef
4.
Lencioni R, Della Pina C, Crocetti L, Bozzi E, Cioni D (2007) Clinical management of focal liver lesions: the key role of real-time contrast-enhanced US. Eur Radiol 17(Suppl 6):F73–F79PubMed
5.
Bolondi L, Correas JM, Lencioni R, Weskott HP, Piscaglia F (2007) New perspectives for the use of contrast-enhanced liver ultrasound in clinical practice. Dig Liver Dis 39(2):187–195PubMedCrossRef
6.
Burns PN, Wilson SR (2007) Focal liver masses: enhancement patterns on contrast-enhanced images—concordance of US scans with CT scans and MR images. Radiology 242(1):162–174PubMedCrossRef
7.
Morana G, Cugini C, Mucelli RP (2008) Small liver lesions in oncologic patients: characterization with CT, MRI and contrast-enhanced US. Cancer Imaging 8 (Spec No A): S132–5
8.
Jeong YY, Yim NY, Kang HK (2005) Hepatocellular carcinoma in the cirrhotic liver with helical CT and MRI: imaging spectrum and pitfalls of cirrhosis-related nodules. AJR Am J Roentgenol 185(4):1024–1032PubMedCrossRef
9.
Hussain SM, Zondervan PE, IJzermans JN, et al. (2002) Benign versus malignant hepatic nodules: MR imaging findings with pathologic correlation. Radiographics 22(5):1023–1036PubMed
10.
Wilson SR, Kim TK, Jang HJ, Burns PN (2007) Enhancement patterns of focal liver masses: discordance between contrast-enhanced sonography and contrast-enhanced CT and MRI. AJR Am J Roentgenol 189(1):W7–W12PubMedCrossRef
11.
Chung YE, Kim MJ, Park YN, et al. (2009) Varying appearances of cholangiocarcinoma: radiologic-pathologic correlation. Radiographics 29(3):683–700PubMedCrossRef
12.
Rimola J, Forner A, Reig M, et al. (2009) Cholangiocarcinoma in cirrhosis: absence of contrast washout in delayed phases by magnetic resonance imaging avoids misdiagnosis of hepatocellular carcinoma. Hepatology 50(3):791–798PubMedCrossRef
13.
Piscaglia F, Lencioni R, Sagrini E, et al. (2010) Characterization of focal liver lesions with contrast-enhanced ultrasound. Ultrasound Med Biol 36(4):531–550PubMedCrossRef
14.
Li R, Zhang X, Hua X, et al. (2010) Real-time contrast-enhanced ultrasonography of resected and immunohistochemically proven hepatic angiomyolipoma. Abdom Imaging 35:676–682PubMedCrossRef
15.
Quaia E, Calliada F, Bertolotto M, et al. (2004) Characterization of focal liver lesions with contrast-specific US modes and a sulfur hexafluoride-filled microbubble contrast agent: diagnostic performance and confidence. Radiology 232:420–430PubMedCrossRef
16.
Murphy-Lavallee J, Jang HJ, Kim TK, Burns PN, Wilson SR (2007) Are metastases really hypovascular in the arterial phase? The perspective based on contrast-enhanced ultrasonography. J Ultrasound Med 26(11):1545–1556PubMed
17.
Nicolau C, Vilana R, Catalá V, et al. (2006) Importance of evaluating all vascular phases on contrast-enhanced sonography in the differentiation of benign from malignant focal liver lesions. AJR Am J Roentgenol 186:158–167PubMedCrossRef
18.
Kim TK, Jang HJ, Burns PN, Murphy-Lavallee J, Wilson SR (2008) Focal nodular hyperplasia and hepatic adenoma: differentiation with low-mechanical-index contrast-enhanced sonography. AJR Am J Roentgenol 190(1):58–66PubMedCrossRef
19.
Bartolotta TV, Tiabbi A, Midiri M, Lagalla R (2009) Focal liver lesions: contrast-enhanced ultrasound. Abdom Imaging 34(2):193–209PubMedCrossRef
20.
Dietrich CF, Schuessler G, Trojan J, Fellbaum C, Ignee A (2005) Differentiation of focal nodular hyperplasia and hepatocellular adenoma by contrast-enhanced ultrasound. Br J Radiol 78(932):704–707PubMedCrossRef
21.
22.
Catala V, Nicolau C, Vilana R, et al. (2007) Characterization of focal liver lesions: comparative study of contrast-enhanced ultrasound versus spiral computed tomography. Eur Radiol 17(4):1066–1073PubMedCrossRef
23.
Quaia E, Alaimo V, Baratella E, et al. (2009) The added diagnostic value of 64-row multidetector CT combined with contrast-enhanced US in the evaluation of hepatocellular nodule vascularity: implications in the diagnosis of malignancy in patients with liver cirrhosis. Eur Radiol 19(3):651–663PubMedCrossRef
24.
Maruyama H, Takahashi M, Ishibashi H, Yoshikawa M, Yokosuka O (2011) Contrast-enhanced ultrasound for characterisation of hepatic lesions appearing non-hypervascular on CT in chronic liver diseases. Br J Radiol [Epub ahead of print]
25.
Bolondi L, Gaiani S, Celli N, et al. (2005) Characterization of small nodules in cirrhosis by assessment of vascularity: the problem of hypovascular hepatocellular carcinoma. Hepatology 42(1):27–34PubMedCrossRef
26.
Kim TK, Lee KH, Khalili K, Jang HJ (2011) Hepatocellular nodules in liver cirrhosis: contrast-enhanced ultrasound. Abdom Imaging 36(3):244–263PubMedCrossRef
27.
Nicolau C, Catalá V, Vilana R, et al. (2004) Evaluation of hepatocellular carcinoma using SonoVue, a second generation ultrasound contrast agent: correlation with cellular differentiation. Eur Radiol 14(6):1092–1099PubMedCrossRef
28.
Bhayana D (2010) Hypervascular liver masses on contrast-enhanced ultrasound: the importance of washout. AJR Am J Roentgenol 194(4):977–983PubMedCrossRef
29.
Jang HJ, Kim TK, Burns PN, Wilson SR (2007) Enhancement patterns of hepatocellular carcinoma at contrast-enhanced US: comparison with histologic differentiation. Radiology 244(3):898–906PubMedCrossRef
30.
Chen LD, Xu HX, Xie XY, et al. (2010) Intrahepatic cholangiocarcinoma and hepatocellular carcinoma: differential diagnosis with contrast-enhanced ultrasound. Eur Radiol 20(3):743–753PubMedCrossRef
31.
Vilana R, Forner A, Bianchi L, et al. (2010) Intrahepatic peripheral cholangiocarcinoma in cirrhosis patients may display a vascular pattern similar to hepatocellular carcinoma on contrast-enhanced ultrasound. Hepatology 51(6):2020–2029PubMedCrossRef
32.
Strobel D, Seitz K, Blank W, et al. (2008) Contrast-enhanced ultrasound for the characterization of focal liver lesions–diagnostic accuracy in clinical practice (DEGUM multicenter trial). Ultraschall Med 29:499–505PubMedCrossRef
33.
Tranquart F, Correas JM, Ladam Marcus V, et al. (2009) Real-time contrast-enhanced ultrasound in the evaluation of focal liver lesions: diagnostic efficacy and economical issues from a French multicentric study. J Radiol 90:109–122PubMedCrossRef
34.
Nicolau Molina C, Fontanilla Echeveste T, Del Cura Rodríguez JL, et al. (2010) Usefulness of contrast-enhanced ultrasonography in daily clinical practice: a multicenter study in Spain. Radiologia 52(2):144–152PubMedCrossRef
35.
Luo W, Numata K, Morimoto M, et al. (2009) Focal liver tumors: characterization with 3D perflubutane microbubble contrast agent-enhanced US versus 3D contrast-enhanced multidetector CT. Radiology 251(1):287–295PubMedCrossRef
36.
Wilson SR, Jang HJ, Kim TK, et al. (2008) Real-time temporal maximum-intensity-projection imaging of hepatic lesions with contrast-enhanced sonography. AJR Am J Roentgenol 190(3):691–965PubMedCrossRef
37.
Salvatore V, Borghi A, Sagrini E, et al. (2011) Quantification of enhancement of focal liver lesions during contrast-enhanced ultrasound (CEUS). Analysis of ten selected frames is more simple but as reliable as the analysis of the entire loop for most parameters. Eur J Radiol [Epub ahead of print]
38.
Schacherer D, Girlich C, Wiest R, et al. (2010) Semiquantitative characterization of hepatocellular carcinoma (HCC)—perfusion with contrast-enhanced ultrasound and perfusion analysis. Clin Hemorheol Microcirc 44(2):97–105PubMed
39.
Albrecht T, Hoffmann CW, Schmitz SA, et al. (2001) Phase-inversion sonography during the liver-specific late phase of contrast enhancement: improved detection of liver metastases. AJR Am J Roentgenol 176(5):1191–1198PubMed
40.
Albrecht T, Blomley MJ, Burns PN, et al. (2003) Improved detection of hepatic metastases with pulse-inversion US during the liver-specific phase of SHU 508A: multicenter study. Radiology 227(2):361–370PubMedCrossRef
41.
Oldenburg A, Hohmann J, Foert E (2005) Detection of hepatic metastases with low MI real time contrast enhanced sonography and SonoVue. Ultraschall Med 26(4):277–284PubMedCrossRef
42.
Chami L, Lassau N, Malka D, et al. (2008) Benefits of contrast-enhanced sonography for the detection of liver lesions: comparison with histologic findings. AJR Am J Roentgenol 190(3):683–690PubMedCrossRef
43.
Correas JM, Low G, Needleman L, et al. (2011) Contrast enhanced ultrasound in the detection of liver metastases: a prospective multi-centre dose testing study using a perfluorobutane microbubble contrast agent (NC100100). Eur Radiol [Epub ahead of print]
44.
Quaia E, D’Onofrio M, Palumbo A, et al. (2006) Comparison of contrast-enhanced ultrasonography versus baseline ultrasound and contrast-enhanced computed tomography in metastatic disease of the liver: diagnostic performance and confidence. Eur Radiol 16(7):1599–1609PubMedCrossRef
45.
Larsen LP, Rosenkilde M, Christensen H, et al. (2009) Can contrast-enhanced ultrasonography replace multidetector-computed tomography in the detection of liver metastases from colorectal cancer? Eur J Radiol 69(2):308–313PubMedCrossRef
46.
Mainenti PP, Mancini M, Mainolfi C, et al. (2010) Detection of colo-rectal liver metastases: prospective comparison of contrast enhanced US, multidetector CT, PET/CT, and 1.5 Tesla MR with extracellular and reticulo-endothelial cell specific contrast agents. Abdom Imaging 35:511–521PubMedCrossRef
47.
Kudo M, Hatanaka K, Maekawa K (2010) Newly developed novel ultrasound technique, defect reperfusion ultrasound imaging, using sonazoid in the management of hepatocellular carcinoma. Oncology 78(Suppl 1):40–45PubMedCrossRef
48.
Torzilli G, Del Fabbro D, Palmisano A, et al. (2005) Contrast-enhanced intraoperative ultrasonography during hepatectomies for colorectal cancer liver metastases. J Gastrointest Surg 9(8):1148–1153PubMedCrossRef
49.
Torzilli G, Olivari N, Moroni E, et al. (2004) Contrast-enhanced intraoperative ultrasonography in surgery for hepatocellular carcinoma in cirrhosis. Liver Transpl 10((2 Suppl 1)):S34–S48PubMedCrossRef
50.
Arii S, Tanaka S, Mitsunori Y, et al. (2010) Surgical strategies for hepatocellular carcinoma with special reference to anatomical hepatic resection and intraoperative contrast-enhanced ultrasonography. Oncology 78(Suppl 1):125–130PubMedCrossRef
51.
Leen E, Ceccotti P, Moug SJ, et al. (2006) Potential value of contrast-enhanced intraoperative ultrasonography during partial hepatectomy for metastases: an essential investigation before resection? Ann Surg 243(2):236–240PubMedCrossRef
52.
Sidhu PS, Shaw AS, Ellis SM, Karani JB, Ryan SM (2004) Microbubble ultrasound contrast in the assessment of hepatic artery patency following liver transplantation: role in reducing frequency of hepatic artery arteriography. Eur Radiol 14(1):21–30PubMedCrossRef
53.
García-Criado A, Gilabert R, Berzigotti A, Brú C (2009) Doppler ultrasound findings in the hepatic artery shortly after liver transplantation. AJR Am J Roentgenol 193(1):128–135PubMedCrossRef
54.
Tarantino L, Francica G, Sordelli I, et al. (2006) Diagnosis of benign and malignant portal vein thrombosis in cirrhotic patients with hepatocellular carcinoma: color Doppler US, contrast-enhanced US, and fine-needle biopsy. Abdom Imaging 31(5):537–544PubMedCrossRef
55.
Rossi S, Ghittoni G, Ravetta V, et al. (2008) Contrast-enhanced ultrasonography and spiral computed tomography in the detection and characterization of portal vein thrombosis complicating hepatocellular carcinoma. Eur Radiol 18(8):1749–1756PubMedCrossRef
56.
Li N, Ding H, Fan P, et al. (2010) Intrahepatic transit time predicts liver fibrosis in patients with chronic hepatitis B: quantitative assessment with contrast-enhanced ultrasonography. Ultrasound Med Biol 36(7):1066–1075PubMedCrossRef
57.
Berzigotti A, Nicolau C, Bellot P, et al. (2010) Evaluation of regional hepatic perfusion (RHP) by contrast-enhanced ultrasound in patients with cirrhosis. J Hepatol 55(2):307–314PubMedCrossRef
58.
Maruyama H, Shimada T, Ishibashi H, et al. (2011) Delayed periportal enhancement: a characteristic finding on contrast ultrasound in idiopathic portal hypertension. Hepatol Int [Epub ahead of print]
59.
Meacock LM, Sellars ME, Sidhu PS (2010) Evaluation of gallbladder and biliary duct disease using microbubble contrast-enhanced ultrasound. Br J Radiol 83(991):615–627PubMedCrossRef
60.
Xie XH, Xu HX, Xie XY, et al. (2010) Differential diagnosis between benign and malignant gallbladder diseases with real-time contrast-enhanced ultrasound. Eur Radiol 20(1):239–248PubMedCrossRef
61.
Ghittoni G, Caturelli E, Viera FT (2010) Intrabile duct metastasis from colonic adenocarcinoma without liver parenchyma involvement: contrast enhanced ultrasonography detection. Abdom Imaging 35(3):346–348PubMedCrossRef
62.
Solbiati L, Tonolini M, Cova L (2004) Monitoring RF ablation. Eur Radiol 14(Suppl 8):P34–P42PubMed
63.
Nicolau C, Vilana R, Bianchi L, Brú C (2007) Early-stage hepatocellular carcinoma: the high accuracy of real-time contrast-enhanced ultrasonography in the assessment of response to percutaneous treatment. Eur Radiol 17(Suppl 6):F80–F88PubMed
64.
Moschouris H, Malagari K, Papadaki MG, et al. (2011) Short-term evaluation of liver tumors after transarterial chemoembolization: limitations and feasibility of contrast-enhanced ultrasonography. Abdom Imaging. doi:10.​1007/​s00261-011-9690-4
65.
Hoeffel C, Pousset M, Timsit MO, et al. (2010) Radiofrequency ablation of renal tumours: diagnostic accuracy of contrast-enhanced ultrasound for early detection of residual tumour. Eur Radiol 20(8):1812–1821PubMedCrossRef
66.
Kong WT, Zhang WW, Guo HQ, et al. (2011) Application of contrast-enhanced ultrasonography after radiofrequency ablation for renal cell carcinoma: is it sufficient for assessment of therapeutic response? Abdom Imaging 36(3):342–347PubMedCrossRef
67.
Yu H, Jang HJ, Kim TK, et al. (2010) Pseudoenhancement within the local ablation zone of hepatic tumors due to a nonlinear artifact on contrast-enhanced ultrasound. AJR Am J Roentgenol 194(3):653–659PubMedCrossRef
68.
Meloni MF, Livraghi T, Filice C, et al. (2006) Radiofrequency ablation of liver tumors: the role of microbubble ultrasound contrast agents. Ultrasound Q 22(1):41–47PubMed
69.
Sala M, Llovet JM, Vilana R, et al. (2004) Initial response to percutaneous ablation predicts survival in patients with hepatocellular carcinoma. Hepatology 40(6):1352–1360PubMedCrossRef
70.
Vilana R, Bianchi L, Varela M, et al. (2006) Is microbubble-enhanced ultrasonography sufficient for assessment of response to percutaneous treatment in patients with early hepatocellular carcinoma? Eur Radiol 16(11):2454–2462PubMedCrossRef
71.
Choi D, Lim HK, Lee WJ, et al. (2003) Early assessment of the therapeutic response to radio frequency ablation for hepatocellular carcinoma: utility of gray scale harmonic ultrasonography with a microbubble contrast agent. J Ultrasound Med 22(11):1163–1172PubMed
72.
Dill-Macky MJ, Asch M, Burns P, Wilson S (2006) Radiofrequency ablation of hepatocellular carcinoma: predicting success using contrast enhanced sonography. AJR Am J Roentgenol 186:287–295CrossRef
73.
Salvaggio G, Campisi A, Lo Greco V, et al. (2010) Evaluation of posttreatment response of hepatocellular carcinoma: comparison of ultrasonography with second-generation ultrasound contrast agent and multidetector CT. Abdom Imaging 35(4):447–453PubMedCrossRef
74.
Cosgrove D, Lassau N (2010) Imaging of perfusion using ultrasound. Eur J Nucl Med Mol Imaging 37(Suppl 1):S65–S85PubMedCrossRef
75.
Lassau N, Chami L, Benatsou B, Peronneau P, Roche A (2007) Dynamic contrast-enhanced ultrasonography (DCE-US) with quantification of tumor perfusion: a new diagnostic tool to evaluate the early effects of antiangiogenic treatment. Eur Radiol 17(Suppl 6):F89–F98PubMed
76.
Lassau N, Koscielny S, Chami L, et al. (2011) Advanced hepatocellular carcinoma: early evaluation of response to bevacizumab therapy at dynamic contrast-enhanced US with quantification–preliminary results. Radiology 258(1):291–300PubMedCrossRef
77.
Williams R, Hudson JM, Lloyd BA, et al. (2011) Dynamic microbubble contrast-enhanced us to measure tumor response to targeted therapy: a proposed clinical protocol with results from renal cell carcinoma patients receiving antiangiogenic therapy. Radiology 260(2):581–590PubMedCrossRef
78.
D′Onofrio M, Zamboni G, Facciolli N, et al. (2007) Ultrasonography of the pancreas. 4. Contrast-enhanced imaging. Abdom Imaging 32:171–181PubMedCrossRef
79.
Rickes S, Mönkemüller K, Malfertheiner P (2007) Acute severe pancreatitis: contrast-enhanced sonography. Abdom Imaging 32:362–364PubMedCrossRef
80.
Rickes S, Mönkemüller K, Malfertheiner P (2006) Contrast-enhanced ultrasound in the diagnosis of pancreatic tumors. J Pancreas 7:584–592
81.
Faccioli N, Crippa S, Bassi C, et al. (2009) Contrast-enhanced ultrasonography of the pancreas. Pancreatology 9:560–566PubMedCrossRef
82.
Malagò R, D′Onofrio M, Zamboni GA, et al. (2009) Contrast-enhanced sonography of nonfunctioning pancreatic neuroendocrine tumors. AJR Am J Roentgenol 192:424–430PubMedCrossRef
83.
Beyer-Enke SA, Hocke M, Ignee A, et al. (2010) Contrast enhanced transabdominal ultrasound in the characterisation of pancreatic lesions with cystic appearance. J Pancreas 11:427–433
84.
D′Onofrio M, Megibow AJ, Faccioli N, et al. (2007) Comparison of contrast-enhanced sonography and MRI in displaying anatomic features of cystic pancreatic masses. AJR Am J Roentgenol 189:1435–1442PubMedCrossRef
85.
Rickes S, Uhle C, Kahl S, et al. (2006) Echo-enhanced ultrasound: a new valid initial imaging approach for severe acute pancreatitis. Gut 55:74–78PubMedCrossRef
86.
Ripollés T, Martínez MJ, López E, et al. (2010) Contrast-enhanced ultrasound in the staging of acute pancreatitis. Eur Radiol 20:2518–2523PubMedCrossRef
87.
Lu Q, Zhong Y, Wen X, et al. (2011) Can contrast-enhanced ultrasound evaluate the severity of acute pancreatitis? Dig Dis Sci 56:1578–1584PubMedCrossRef
88.
Stang A, Keles H, Hentschke S, et al. (2009) Differentiation of benign from malignant focal splenic lesions using sulphur hexafluoride-filled microbubble contrast-enhanced pulse-inversion sonography. AJR Am J Roentgenol 193:709–721PubMedCrossRef
89.
90.
91.
Quaia E, Bertolotto M, Cioffi V, et al. (2008) Comparison of contrast-enhanced sonography with unenhanced sonography and contrast-enhanced CT in the diagnosis of malignancy in complex cystic renal masses. AJR Am J Roentgenol 191:1239–1249PubMedCrossRef
92.
Park BK, Kim B, Kim SH, et al. (2007) Assessment of cystic renal masses based on Bosniak classification: comparison of CT and contrast-enhanced US. Eur J Radiol 61:310–314PubMedCrossRef
93.
Clevert DA, Minaifar N, Weckbach S, et al. (2008) Multislice computed tomography versus contrast-enhanced ultrasound in evaluation of complex cystic renal masses using the Bosniak classification system. Clin Hemorheol Microcirc 39:171–178PubMed
94.
Ascenti G, Zimbaro G, Mazziotti S, et al. (2001) Contrast-enhanced power Doppler US in the diagnosis of renal pseudotumors. Eur Radiol 11(12):2496–2499PubMedCrossRef
95.
Mazziotti S, Zimbaro F, Pandolfo A, et al. (2010) Usefulness of contrast-enhanced ultrasonography in the diagnosis of renal pseudotumors. Abdom Imaging 35:241–245PubMedCrossRef
96.
Xu ZF, Xu HX, et al. (2010) Renal cell carcinoma: real-time contrast-enhanced ultrasound findings. Abdom Imaging 35:750–756PubMedCrossRef
97.
Moschouris H, Stamatiou K, Kornezos I, et al. (2010) Renal cell carcinoma: real-time contrast-enhanced ultrasound findings. Abdom Imaging 35:507–509PubMedCrossRef
98.
Ascenti G, Gaeta M, Magno C, et al. (2004) Contrast-enhanced second-harmonic sonography in the detection of pseudocapsule in renal cell carcinoma. AJR Am J Roentgenol 182(6):1525–1530PubMed
99.
Correas JM, Claudon M, Tranquart F, Hélénon AO (2006) The kidney: imaging with microbubble contrast agents. Ultrasound Q 22(1):53–66PubMed
100.
Setola SV, Catalano O, Sandomenico F, Siani A (2007) Contrast-enhanced sonography of the kidney. Abdom Imaging 32:21–28PubMedCrossRef
101.
Jiang J, Chen Y, Zhou Y, Zhang H (2010) Clear cell renal cell carcinoma: contrast-enhanced ultrasound features relation to tumor size. Eur J Radiol 73(1):162–167PubMedCrossRef
102.
Fischer T, Dieckhöfer J, Mühler M, et al. (2005) The use of contrast-enhanced US in renal transplant: first results and potential clinical benefit. Eur Radiol 15(Suppl 5):E109–E116PubMed
103.
Benozzi L, Cappelli G, Granito M, et al. (2009) Contrast-enhanced sonography in early kidney graft dysfunction. Transplant Proc 41(4):1214–1215PubMedCrossRef
104.
Mitterberger M, Pinggera GM, Colleselli D, et al. (2008) Acute pyelonephritis: comparison of diagnosis with computed tomography and contrast-enhanced ultrasonography. BJU Int 101(3):341–344PubMedCrossRef
105.
Granata A, Andrulli S, Fiorini F, et al. (2011) Diagnosis of acute pyelonephritis by contrast-enhanced ultrasonography in kidney transplant patients. Nephrol Dial Transplant 26(2):715–720PubMedCrossRef
106.
Catalano O, Aiani L, Barozzi L, et al. (2009) CEUS in abdominal trauma: multi-center study. Abdom Imaging 34(2):225–234PubMedCrossRef
107.
Lebkowska U, Janica J, Lebkowski W, et al. (2009) Renal parenchyma perfusion spectrum and resistive index (RI) in ultrasound examinations with contrast medium in the early period after kidney transplantation. Transplant Proc 41(8):3024–3027PubMedCrossRef
108.
Berrocal T, Gayá F, Arjonilla A (2005) Vesicoureteral reflux: can the urethra be adequately assessed by using contrast-enhanced voiding US of the bladder? Radiology 234(1):235–241PubMedCrossRef
109.
Duran C, Valera A, Alguersuari A, et al. (2009) Voiding urosonography: the study of the urethra is no longer a limitation of the technique. Pediatr Radiol 39(2):124–131PubMedCrossRef
110.
Nicolau C, Bunesch L, Peri L, et al. (2010) Accuracy of contrast-enhanced ultrasound in the detection of bladder cancer. Br J Radiol [Epub ahead of print]
111.
Nicolau C, Bunesch L, Sebastia C, Salvador R (2010) Diagnosis of bladder cancer: contrast-enhanced ultrasound. Abdom Imaging 35(4):494–503PubMedCrossRef
112.
Caruso G, Salvaggio G, Campisi A, et al. (2010) Bladder tumor staging: comparison of contrast-enhanced and gray-scale ultrasound. AJR Am J Roentgenol 194(1):151–156PubMedCrossRef
113.
Sano F, Terao H, Kawahara T, et al. (2011) Contrast-enhanced ultrasonography of the prostate: various imaging findings that indicate prostate cancer. BJU Int 107(9):1404–1410PubMedCrossRef
114.
Aigner F, Pallwein L, Mitterberger M, et al. (2009) Contrast-enhanced ultrasonography using cadence-contrast pulse sequencing technology for targeted biopsy of the prostate. BJU Int 103:458–463PubMedCrossRef
115.
Wink M, Frauscher F, Cosgrove D, et al. (2008) Contrast-enhanced ultrasound and prostate cancer; a multicentre European research coordination project. Eur Radiol 54:982–992
116.
Pallwein L, Mitterberger M, Pelzer A, et al. (2008) Ultrasound of prostate cancer: recent advances. Eur Radiol 18:707–715PubMedCrossRef
117.
Migaleddu V, Quaia E, Scano D, et al. (2008) Inflammatory activity in Crohn′s disease: ultrasound findings. Abdom Imaging 33:589–597PubMedCrossRef
118.
Serra C, Menozzi G, Morselli AM, et al. (2007) Ultrasound assessment of vascularization of the thickened terminal ileum wall in Crohn′s disease patients using a low-mechanical index real-time scanning technique with a second generation ultrasound contrast agent. Eur J Radiol 62:114–121PubMedCrossRef
119.
Migaleddu V, Scanu AM, Quaia E, et al. (2009) Contrast-enhanced ultrasonographic evaluation of inflammatory activity in Crohn′s disease. Gastroenterology 137:43–61PubMedCrossRef
120.
Ripollés T, Martínez-Perez MJ, Paredes JM, et al. (2009) Crohn′s disease: correlation of findings at contrast-enhanced US with endoscopic severity at endoscopy. Radiology 253:241–248PubMedCrossRef
121.
Quaia E, Migaleddu V, Baratella E, et al. (2009) The diagnostic value of small bowel wall vascularity after sulfur hexafluoride-filled microbuble injection in patients with Crohn’s disease. Correlation with the therapeutic effectiveness of specific anti-inflammatory treatment. Eur J Radiol 69(3):438–445PubMedCrossRef
122.
Migaleddu V, Quaia E, Scanu D, et al. (2011) Inflammatory activity in Crohn’s disease: CEUS. Abdom Imaging 36:142–148PubMedCrossRef
123.
Robotti D, Cammarota T, Debani P, et al. (2004) Activity of Crohn disease: value of color-power Doppler and contrast-enhanced ultrasonography. Abdom Imaging 29:648–652PubMedCrossRef
124.
Kratzer W, Schmidt SA, Mittrach Ch, et al. (2005) Contrast-enhanced wideband harmonic imaging ultrasound (SonoVue): a new technique for quantifying bowel wall vascularity in Crohn’s disease. Scand J Gastroenterol 40:985–991PubMedCrossRef
125.
Pellicer B, Romá E, Ripollés T, et al. (2010) Effectiveness of contrast-enhanced US for characterization of intestinal strictures in Crohn disease [abstract]. In: Radiological Society of North America scientific assembly and annual meeting program, RSNA
126.
Catalano O, Aiani L, Barozzi L, et al. (2009) CEUS in abdominal trauma: multi-center study. Abdom Imaging 34:225–234PubMedCrossRef
127.
Valentino M, Serra C, Zironi G, et al. (2006) Blunt abdominal trauma: emergency contrast-enhanced sonography for detection of solid organ injuries. AJR Am J Roentgenol 186:1361–1367PubMedCrossRef
128.
McGahan JP, Horton S, Gerscovich EO, et al. (2006) Appearance of solid organ injury with contrast-enhanced sonography in blunt abdominal trauma: preliminary experience. AJR Am J Roentgenol 187:658–666PubMedCrossRef
129.
Valentino M, Serra C, Pavlica P, et al. (2008) Blunt abdominal trauma: diagnostic performance of contrast-enhanced US in children—initial experience. Radiology 246:903–909PubMedCrossRef
130.
Clevert DA, Weckbach S, Minaifar N, et al. (2008) Contast-enhanced ultrasound versus MS-CT in blunt abdominal trauma. Clin Hemorheol Microcirc 39:155–169PubMed
131.
Catalano O, Cusati B, Nunziata A, Siani A (2006) Active abdominal bleeding: contrast-enhanced sonography. Abd Imaging 31:9–16CrossRef
132.
Poletti PA, Platon A, Becker ChD, et al. (2004) Blunt abdominal trauma: does the use of a second-generation sonographic contrast agent help to detect solid organ injuries? AJR Am J Roentgenol 183:1293–1301PubMed
133.
Manabe N, Hata J, Haruma K, et al. (2010) Active gastrointestinal bleeding: evaluation with contrast-enhanced ultrasonography. Abdom Imaging 35:637–642PubMedCrossRef
134.
Mirza TA, Karthikesalingam A, Jackson D, et al. (2010) Duplex ultrasound and contrast-enhanced ultrasound versus computed tomography for the detection of Endoleak after EVAR: systematic review and bivariate meta-analysis. Eur J Vasc Endovasc Surg 39(4):418–428PubMedCrossRef
135.
Iezzi R, Cotroneo R, Basilico R, et al. (2010) Endoleaks after endovascular repair of abdominal aortic aneurysm: value of CEUS. Abdom Imaging 35:106–114PubMedCrossRef
136.
Carrafiello G, Recaldini C, Laganà D, et al. (2008) Endoleak detection and classification after endovascular treatment of abdominal aortic aneurysm: value of CEUS over CT. Abdom Imaging 33:357–362PubMedCrossRef
137.
Dill-Mucky MJ, Wilson SR, Sternbach Y, et al. (2007) Detecting endoleaks in aortic endografts using contrast-enhanced sonography. AJR Am J Roentgenol 188:262–268CrossRef
Metadata
Title
Contrast-enhanced ultrasound in abdominal imaging
Authors
Carlos Nicolau
Tomás Ripollés
Publication date
01-02-2012
Publisher
Springer-Verlag
Published in
Abdominal Radiology / Issue 1/2012
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-011-9796-8

Other articles of this Issue 1/2012

Abdominal Radiology 1/2012 Go to the issue

OriginalPaper

Small intestinal vascular malformation bleeding: diagnosis by double-balloon enteroscopy combined with abdominal contrast-enhanced CT examination

Pictorial Essay

Relapse of Crohn’s disease following ileal pouch-anal anastomosis: MDCT and MR features

OriginalPaper

Common and unusual diseases involving the iliopsoas muscle compartment: spectrum of cross-sectional imaging findings

ReviewPaper

Whole-body MR/PET: applications in abdominal imaging

OriginalPaper

Diagnostic yield of capsule endoscopy for gastric diseases

Letter to the Editor

RE: Mass lesions in chronic pancreatitis: benign or malignant? An “evidence-based practice” approach. A caveat regarding autoimmune pancreatitis
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits